Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Hempel

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Electrophoresis|September 3, 2015
Quantitative analysis of DNA methylation in the promoter region of the methylguanine-O(6) -DNA-methyltransferase gene by COBRA and subsequent native capillary gel electrophoresisSimon Goedecke, Jörg Mühlisch, Georg Hempel, et al.
Scientific Reports|October 30, 2020
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoringChristian Siebel, Claudia Lanvers-Kaminsky, Gudrun Würthwein, et al.
Therapeutic Drug Monitoring|November 23, 2011
Minimization of the preanalytical error in plasma samples for pharmacokinetic analyses and therapeutic drug monitoring--using doxorubicin as an exampleNina E Kontny, Georg Hempel, Joachim Boos, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2014
Comparative pharmacokinetic/pharmacodynamic characterisation of a new pegylated recombinant E. coli L-asparaginase preparation (MC0609) in Beagle dogStephan Borghorst, Georg Hempel, Sabine Poppenborg, et al.
Clinical Pharmacokinetics|April 13, 2017
Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in PregnancyAndré Dallmann, Ibrahim Ince, Michaela Meyer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 5, 2020
Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after deliveryAndré Dallmann, Anneke Himstedt, Juri Solodenko, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2011
Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to childrenGisela Kersting, Stefan Willmann, Gudrun Würthwein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in childrenMirjam N Trame, Martin Bergstrand, Mats O Karlsson, et al.
Springerplus|June 18, 2014
Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modelingKristin Dickschen, Thomas Eissing, Thomas Mürdter, et al.
Clinical Pharmacokinetics|June 14, 2021
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic ApproachLisa Alina Kneller, Pablo Zubiaur, Dora Koller, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Electrophoresis|September 3, 2015
Quantitative analysis of DNA methylation in the promoter region of the methylguanine-O(6) -DNA-methyltransferase gene by COBRA and subsequent native capillary gel electrophoresisSimon Goedecke, Jörg Mühlisch, Georg Hempel, et al.
Scientific Reports|October 30, 2020
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoringChristian Siebel, Claudia Lanvers-Kaminsky, Gudrun Würthwein, et al.
Therapeutic Drug Monitoring|November 23, 2011
Minimization of the preanalytical error in plasma samples for pharmacokinetic analyses and therapeutic drug monitoring--using doxorubicin as an exampleNina E Kontny, Georg Hempel, Joachim Boos, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2014
Comparative pharmacokinetic/pharmacodynamic characterisation of a new pegylated recombinant E. coli L-asparaginase preparation (MC0609) in Beagle dogStephan Borghorst, Georg Hempel, Sabine Poppenborg, et al.
Clinical Pharmacokinetics|April 13, 2017
Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in PregnancyAndré Dallmann, Ibrahim Ince, Michaela Meyer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 5, 2020
Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after deliveryAndré Dallmann, Anneke Himstedt, Juri Solodenko, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2011
Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to childrenGisela Kersting, Stefan Willmann, Gudrun Würthwein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in childrenMirjam N Trame, Martin Bergstrand, Mats O Karlsson, et al.
Springerplus|June 18, 2014
Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modelingKristin Dickschen, Thomas Eissing, Thomas Mürdter, et al.
Clinical Pharmacokinetics|June 14, 2021
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic ApproachLisa Alina Kneller, Pablo Zubiaur, Dora Koller, et al.
Pageof 13